[1]傅 青,易云佩.益母草胶囊治疗产后子宫复旧不良的临床效果及对产妇月经恢复的影响[J].医学信息,2022,35(21):137-139.[doi:10.3969/j.issn.1006-1959.2022.21.036]
　FU Qing,YI Yun-pei.The Clinical Effect of Yimucao Capsule in the Treatment of Postpartum Uterine Involution and its Effect on Maternal Menstrual Recovery[J].Journal of Medical Information,2022,35(21):137-139.[doi:10.3969/j.issn.1006-1959.2022.21.036]
点击复制

益母草胶囊治疗产后子宫复旧不良的临床效果及对产妇月经恢复的影响()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
35卷
期数:
2022年21期
页码:
137-139
栏目:
药物与临床
出版日期:
2022-11-01

文章信息/Info

Title:
The Clinical Effect of Yimucao Capsule in the Treatment of Postpartum Uterine Involution and its Effect on Maternal Menstrual Recovery
文章编号:
1006-1959（2022）21-0136-03
作者:
傅 青; 易云佩
（永丰县妇幼保健院药剂科，江西 永丰 331599）
Author(s):
FU Qing; YI Yun-pei
(Department of Pharmacy,Yongfeng Maternal and Child Health Hospital,Yongfeng 331599,Jiangxi,China)
关键词:
子宫复旧不良; 益母草胶囊; 缩宫素; 恶露
Keywords:
Poor uterine involution; Yimucao capsules; Oxytocin; Lochia
分类号:
R714.46
DOI:
10.3969/j.issn.1006-1959.2022.21.036
文献标志码:
A
摘要:
目的 观察益母草胶囊治疗产后子宫复旧不良的临床效果及对产妇月经恢复情况的影响。方法 选取2020年5月-2021年5月永丰县妇幼保健院收治的68例产后子宫复旧不良患者，采用随机数字表法分为对照组（34例）与观察组（34例）。对照组应用缩宫素治疗，观察组在对照组的基础上联合益母草胶囊治疗，比较两组临床疗效、恶露持续时间、宫缩痛持续时间、子宫体积、血常规指标[红细胞计数（RBC）、血红蛋白（Hb）、血小板计数（PLT）]、月经恢复时间、清宫术实施率及晚期产后出血率。结果 观察组总有效率高于对照组（P＜0.05）；观察组恶露持续时间、宫缩痛持续时间短于对照组，子宫体积小于对照组（P＜0.05）；两组RBC、Hb水平高于治疗前，PLT低于治疗前，且观察组RBC、Hb高于对照组，PLT低于对照组（P＜0.05）；观察组月经恢复时间短于对照组，清宫术实施率、晚期产后出血率低于对照组（P＜0.05）。结论 益母草胶囊治疗产后子宫复旧不良效果良好，可加快子宫收缩，缩短产妇恢复时间，改善产妇血液状态，降低清宫术实施率与晚期产后出血风险，促进月经恢复，值得临床应用。
Abstract:
Objective To observe the clinical effect of Yimucao capsule in the treatment of postpartum uterine involution and its influence on menstrual recovery.Methods A total of 68 patients with poor postpartum uterine involution admitted to Yongfeng County Maternal and Child Health Hospital from May 2020 to May 2021 were selected and divided into control group (34 cases) and observation group (34 cases) by random number table method. The control group was treated with oxytocin, and the observation group was treated with Yimucao capsule on the basis of the control group. The clinical efficacy, duration of lochia, duration of uterine contraction pain, uterine volume, blood routine indexes [red blood cell count (RBC), hemoglobin (Hb), platelet count (PLT)], menstrual recovery time, implementation rate of uterine curettage and late postpartum hemorrhage rate were compared between the two groups.Results The total effective rate of the observation group was higher than that of the control group (P<0.05). The duration of lochia and uterine contraction pain in the observation group was shorter than that in the control group, and the uterine volume was smaller than that in the control group (P<0.05). The levels of RBC and Hb in the two groups were higher than those before treatment, while PLT was lower than that before treatment, and the levels of RBC and Hb in the observation group were higher than those in the control group, while PLT was lower than that in the control group (P<0.05). The menstrual recovery time of the observation group was shorter than that of the control group, and the implementation rate of uterine curettage and late postpartum hemorrhage rate were lower than those of the control group (P<0.05).Conclusion Yimucao capsule has a good effect in the treatment of postpartum uterine involution, which can accelerate uterine contraction, shorten maternal recovery time, improve maternal blood status, reduce the implementation rate of uterine curettage and the risk of late postpartum hemorrhage, and promote menstrual recovery. It is worthy of clinical application..

参考文献/References:

[1]张秀芳.益母草胶囊联合缩宫素在药物流产后阴道出血中的应用[J].深圳中西医结合杂志,2019,29(2):38-40.[2]卢余莉,苏艳琼.中西医结合治疗产后子宫复旧不全疗效观察[J]. 湖北中医药大学学报,2015(2):93-94.[3]Paliulyte V,Drasutiene GS,Ramasauskaite D,et al.Physiological Uterine Involution in Primiparous and Multiparous Women: Ultrasound Study[J].Obstetrics and Gynecology International,2017,2017:6739345.[4]郭静,王建军,童晓文,等.缩宫素联合鲜益母草胶囊及缩宫素联合五加生化胶囊治疗产后子宫复旧不良的临床疗效比较[J].中国性科学,2018,27(6):124-127.[5]罗伟飞.益母草胶囊促进产妇子宫复旧疗效观察[J].新中医,2016,48(4):122-123. [6]邓宇芳.生化汤与益母草胶囊治疗产后胎盘胎膜残留的对照研究[J].中国医药科学,2017,7(20):85-88.[7]张飞虹,杨丽琼.复方益母草胶囊综合治疗产后恶露不尽疗效观察[J].辽宁中医杂志,2015,42(5):1034-1036.[8]钟萍.复方益母草胶囊联合米非司酮治疗产后恶露不尽临床观察[J].辽宁中医药大学学报,2016,18(12):204-206. [9]丁南萍,康建颖.中药汤剂联合复方益母草胶囊治疗剖宫产后恶露不绝临床疗效观察[J].中华中医药学刊,2017,35(6):1604-1606. [10]王丙娟,汤传梅,孙慧霞.益气凉血安宫汤联合益母草片治疗产后子宫复旧不全效果分析[J].中华中医药学刊,2021,39(11):77-79.[11]张立巧,乔宗旭,杜亚青,等.益气消瘀汤联合复方益母草胶囊对产后恶露不尽的影响[J].陕西中医,2017,38(4):442-443. [12]金春霞.益母草胶囊治疗产后出血的疗效及对纤维蛋白原、纤维蛋白原降解产物和D-二聚体水平的影响[J].中国妇幼保健,2019,34(3):528-530. [13]Lan S,Liu L,Zong S,et al.Traditional Chinese medicine Guizhi Fuling capsule used for therapy of dysmenorrhea via attenuating uterus contraction[J].Journal of Ethnopharmacology,2016,15(191):273-279.[14]栾会玲,业康,金祖汉,等.鲜益母草胶囊促进药物流产不全大鼠子宫复旧的实验研究[J].中国中医药科技,2021,28(2):200-203.[15]谢妮,包燕,陶春妙.生化汤联合鲜益母草胶囊治疗产后恶露不绝、腰腹疼痛的临床观察[J].中国生化药物杂志,2016(10):105-107.[16]Fan J,Wei F,Zhang Y,et al.Combining Sprague-Dawley rat uterus cell membrane chromatography with HPLC/MS to screen active components from Leonurus artemisia[J].Pharmaceutical Biology,2016,54(2):279.[17]徐雪琼,谭毅.自拟中药汤剂联合复方益母草胶囊治疗剖宫产后恶露探讨[J].江西医药,2021,56(6):817-818,830.[18]王定珺,陈远丽,陈志美.黄体酮胶囊联合益母草胶囊治疗药物流产术后阴道出血的疗效及子宫功能恢复评估[J].解放军预防医学杂志,2019,37(3):146-147.[19]马海燕,陈素华.复方益母草胶囊治疗血瘀型产后恶露不绝的疗效观察[J].中国中医药科技,2020,27(3):473-474.[20]朱彦霏,王毅,周静,等.鲜益母草胶囊联合缩宫素促进产后子宫复旧临床观察[J].新中医,2017,49(6):83-85.[21]江中芳,朱全姿,王珍华.生物电刺激联合益母草在产后恶露不尽治疗中的应用效果[J].医学信息,2021,34(22):142-144.[22]胡卫红.鲜益母草胶囊联合生化汤治疗产后恶露不绝临床观察[J].中国民族民间医药,2018,27(8):109-111.

更新日期/Last Update: 1900-01-01